Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
The Safety and Efficacy of Fractional Ablative 10, 600nm CO2 Laser-assisted Treatments for Male Pattern Hair Loss: a Randomized Cohort Study Comparing Stand-alone Laser Treatment, Laser Assisted Drug Delivery of Minoxidil 2% Solution , and Laser Assisted Drug Delivery of Minoxidil 2% Solution Plus Self-administration of Minoxidil 5% at Home.
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Withdrawn
- Declared phase
- Phase 2
- Sponsor
- University of Minnesota
- Participants (registry)
- —
- Start
- September 2022 (planned)
- Primary completion
- July 2023
- Study completion
- July 2023
- Last registry update
- September 2023
- Countries
- United States
Conditions studied: Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness
Interventions: Post-Laser Minoxidil 2%, Rogaine, At-Home Minoxidil 5%, Rogaine, Laser, Post-laser 5mg minoxidil, Rogaine, Post-laser 10mg minoxidil, Rogaine, Post-laser 20mg minoxidil, Rogaine
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.